• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

A decades-old glaucoma drug tossed aside by Pfizer gets a new life at a small biotech

cafead

Administrator
Staff member
  • cafead   Aug 10, 2021 at 11:02: AM
via Months ago, Pfizer made a grim announcement that it would stop manufacturing phospholine iodide, its decades-old “miracle drug” for a rare form of glaucoma. The pharma said its inventory would run dry by May 2021, leaving some patients with few options short of surgery.

article source